Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Baxter
Medtronic
Federal Trade Commission
Healthtrust
Queensland Health
Teva
Moodys

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075476

« Back to Dashboard

NDA 075476 describes CARTEOLOL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Bausch And Lomb, and Sandoz Inc, and is included in three NDAs. It is available from two suppliers. Additional details are available on the CARTEOLOL HYDROCHLORIDE profile page.

The generic ingredient in CARTEOLOL HYDROCHLORIDE is carteolol hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
Summary for 075476
Tradename:CARTEOLOL HYDROCHLORIDE
Applicant:Sandoz Inc
Ingredient:carteolol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 075476
Mechanism of ActionAdrenergic beta-Antagonists
Medical Subject Heading (MeSH) Categories for 075476
Suppliers and Packaging for NDA: 075476
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARTEOLOL HYDROCHLORIDE carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075476 ANDA Sandoz Inc 61314-238 N 61314-238-05
CARTEOLOL HYDROCHLORIDE carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075476 ANDA Sandoz Inc 61314-238 N 61314-238-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength1%
Approval Date:Jan 3, 2000TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Baxter
Citi
Cantor Fitzgerald
US Army
Cerilliant
UBS
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.